# Qingdao BAHEAL Pharmaceutical Co.,Ltd. – FDA Inspection, Dec 6, 2019

Source: https://www.keypedia.com/records/fda_inspections/qingdao-baheal-pharmaceutical-coltd/d37f9f84-2b56-47ba-b6ed-103d4250a369
Source feed: FDA_Inspections

> FDA inspection 1114238 of Qingdao BAHEAL Pharmaceutical Co.,Ltd., December 06, 2019. Classification: Voluntary Action Indicated (VAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1114238
- Company Name: Qingdao BAHEAL Pharmaceutical Co.,Ltd.
- Inspection Date: 2019-12-06
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1237545 - 2024-03-22
- [FDA Inspection 1032012 - 2017-09-29](https://www.keypedia.com/records/fda_inspections/qingdao-baheal-pharmaceutical-coltd/3cc244f1-4c85-4786-bddd-cd83f25a4aff)
- FDA Inspection 991461 - 2016-10-21

Company: https://www.keypedia.com/companies/qingdao-baheal-pharmaceutical-coltd/c669eb8e-0a82-43e1-a4e2-a3b5db759fe7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c